Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin : a case report and a review of literature
© Author (s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology..
Background. Thrombotic microangiopathies (TMA) are relatively rare but severe disorders characterised by non-immune haemolytic anaemia, thrombocytopaenia and organ failure. In patients with metastatic cancer, sporadic forms of TMA can be triggered by chemotherapeutic agents or can occur as complication of malignancy itself or of infections. Case report. Hereby, we report a case of a patient diagnosed with metastatic colorectal cancer who experienced an atypical haemolytic-uraemic syndrome (aHUS) during chemotherapy treatment with FOLFOX6 scheme. The use of eculizumab led to prompt recovery of laboratory parameters that was maintained despite treatment discontinuation due to appearance of pneumonia infectious. Additionally, genetic analyses revealed the presence in heterozygosis of CFH gene polymorphisms associated with aHUS. Conclusion. This case emphasises the importance of considering TMA as a possible diagnosis in patients with cancer presenting with haemolytic non-immune mediate anaemia and thrombocytopaenia associated with worsening of renal function. Prompt diagnosis is crucial for the requirement of its specific treatment that can impact on long-term outcome and prognosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
---|---|
Enthalten in: |
ESMO open - 4(2019), 5 vom: 21., Seite e000551 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Viscardi, Giuseppe [VerfasserIn] |
---|
Links: |
---|
Themen: |
Atypical haemolytic-uraemic syndrome |
---|
Anmerkungen: |
Date Revised 26.01.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1136/esmoopen-2019-000551 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM30277887X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM30277887X | ||
003 | DE-627 | ||
005 | 20231225111437.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/esmoopen-2019-000551 |2 doi | |
028 | 5 | 2 | |a pubmed24n1009.xml |
035 | |a (DE-627)NLM30277887X | ||
035 | |a (NLM)31673427 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Viscardi, Giuseppe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin |b a case report and a review of literature |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 26.01.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © Author (s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. | ||
520 | |a Background. Thrombotic microangiopathies (TMA) are relatively rare but severe disorders characterised by non-immune haemolytic anaemia, thrombocytopaenia and organ failure. In patients with metastatic cancer, sporadic forms of TMA can be triggered by chemotherapeutic agents or can occur as complication of malignancy itself or of infections. Case report. Hereby, we report a case of a patient diagnosed with metastatic colorectal cancer who experienced an atypical haemolytic-uraemic syndrome (aHUS) during chemotherapy treatment with FOLFOX6 scheme. The use of eculizumab led to prompt recovery of laboratory parameters that was maintained despite treatment discontinuation due to appearance of pneumonia infectious. Additionally, genetic analyses revealed the presence in heterozygosis of CFH gene polymorphisms associated with aHUS. Conclusion. This case emphasises the importance of considering TMA as a possible diagnosis in patients with cancer presenting with haemolytic non-immune mediate anaemia and thrombocytopaenia associated with worsening of renal function. Prompt diagnosis is crucial for the requirement of its specific treatment that can impact on long-term outcome and prognosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a atypical haemolytic-uraemic syndrome | |
650 | 4 | |a colorectal cancer | |
650 | 4 | |a eculizumab | |
650 | 4 | |a thrombotic microangiopathies | |
700 | 1 | |a Zanaletti, Nicoletta |e verfasserin |4 aut | |
700 | 1 | |a Ferrara, Maria Giovanna |e verfasserin |4 aut | |
700 | 1 | |a Sica, Antonello |e verfasserin |4 aut | |
700 | 1 | |a Falcone, Umberto |e verfasserin |4 aut | |
700 | 1 | |a Guastafierro, Salvatore |e verfasserin |4 aut | |
700 | 1 | |a Bracale, Umberto |e verfasserin |4 aut | |
700 | 1 | |a Ribero, Dario |e verfasserin |4 aut | |
700 | 1 | |a Fasano, Morena |e verfasserin |4 aut | |
700 | 1 | |a Napolitano, Stefania |e verfasserin |4 aut | |
700 | 1 | |a Vitale, Pasquale |e verfasserin |4 aut | |
700 | 1 | |a De Falco, Vincenzo |e verfasserin |4 aut | |
700 | 1 | |a Giunta, Emilio Francesco |e verfasserin |4 aut | |
700 | 1 | |a Martinelli, Erika |e verfasserin |4 aut | |
700 | 1 | |a Ciardiello, Davide |e verfasserin |4 aut | |
700 | 1 | |a Ciardiello, Fortunato |e verfasserin |4 aut | |
700 | 1 | |a Troiani, Teresa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ESMO open |d 2016 |g 4(2019), 5 vom: 21., Seite e000551 |w (DE-627)NLM266189539 |x 2059-7029 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2019 |g number:5 |g day:21 |g pages:e000551 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/esmoopen-2019-000551 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 4 |j 2019 |e 5 |b 21 |h e000551 |